Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction
a Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN b The University of Minnesota Medical School, Minneapolis, MN c University of Minnesota Clinical Cell Therapy Laboratory, St Paul, MN